Miljkovic Milos's Form 4 filing
Cartesian Therapeutics, Inc. (RNAC) · filed Jan 8, 2026
- Accession no.
- 0001453687-26-000046
- Filed
- Jan 8, 2026
- Trade date
- Jan 6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $24.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miljkovic MilosCIK 0002000282 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | SSaleDisposed | −3,573 | $6.82F1 | −$24,367.86 | 58,820 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
Referenced by the price of 1 transaction in Table I.